Patent directory · USPTO A61K / A61P
Patents matching “inhibitors”
2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 7388002
Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
granted -
US 7381825
Histone deacetylase inhibitors
granted -
US 7378403
Akt inhibitors, pharmaceutical compositions, and uses thereof
granted -
US 7378422
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
granted -
US 7378552
Monoamine re-uptake inhibitors and methods relating thereto
granted -
US 7375228
Histone deacetylase inhibitors
granted -
US 7375079
Previns as specific inhibitors and therapeutic agents for botulinum toxin B and tetanus neurotoxins
granted -
US 7371372
Compositions comprising IMPDH inhibitors and uses thereof for treating HCV infection
granted -
US 7368452
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
granted -
US 7365072
Inhibitors of p38
granted -
US 7365092
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
granted -
US 7361665
Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
granted -
US 7358273
Inhibitors of caspases
granted -
US 7358259
HCV inhibitors and methods of using them
granted -
US 7354928
Small molecule inhibitors targeted at Bcl-2
granted -
US 7354919
Isoxazole compositions useful as inhibitors of ERK
granted -
US 7354580
Method of administering and using VEGF inhibitors for the treatment of human cancer
granted -
US 7354939
Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto
granted -
US 7354578
Method of tumor regression with VEGF inhibitors
granted -
US 7351702
Caspase inhibitors and uses thereof
granted -
US 7348335
Compositions useful as inhibitors of JAK and other protein kinases
granted -
US 7345054
Heterocyclic inhibitors of ERK2 and uses thereof
granted -
US 7338961
Sphingosine kinase inhibitors
granted -
US 7335662
Substituted tricyclic compounds as protein kinase inhibitors
granted